Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

ONCO

OMX
Market closed
Access this stock data via API
Subscribe
Oncopeptides AB
0
0
0%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 13.3M 9.9M 8.5M 8.2M
Cost of revenue -85K 727K 701K 947K
Gross profit 13.4M 9.2M 7.8M 7.2M
Operating expense
Research & development 28.7M 43.2M 21.9M 27.9M
Selling general and admin 45.3M 50.8M 48.2M 52.6M
Other operating expenses -841K -1.4M -1.1M -14K
Operating income -59.8M -83.3M -61.3M -73.3M
Non operating interest income
Income
Expense
Other income expense
Pretax income -60.6M -82.6M -60.6M -73.2M
Tax provision 46K 789K -366K 22K
Net income -60.7M -83.4M -60.2M -73.2M
Basic EPS -0.3 -0.4 -0.3 -0.5
Diluted EPS -0.3 -0.4 -0.3 -0.5
Basic average shares 209.2M 213.9M 207.7M 152.6M
Diluted average shares 209.2M 213.9M 207.7M 152.6M
EBITDA -59.8M -83.3M -61.3M -73.3M
Net income from continuing op. -59.8M -83.3M -61.3M -73.3M
Minority interests
Preferred stock dividends 0 0 0 0
Market closed

Exchange is currently closed (non-working day)
Main market opens in 1 day 17 hours 3 minutes

15:56
00:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).